RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 164 filers reported holding RELAY THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,035 | -33.0% | 2,263,360 | 0.0% | 0.01% | -31.6% |
Q2 2023 | $28,428 | -22.3% | 2,263,360 | +1.9% | 0.02% | -26.9% |
Q1 2023 | $36,590 | +22.1% | 2,221,580 | +10.7% | 0.03% | +13.0% |
Q4 2022 | $29,978 | -99.9% | 2,006,541 | +10.8% | 0.02% | -28.1% |
Q3 2022 | $40,526,000 | – | 1,811,603 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Grace Capital | 183,112 | $5,665,000 | 3.48% |
Casdin Capital, LLC | 3,668,574 | $115,670,000 | 2.88% |
SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $879,843,000 | 2.73% |
BVF INC/IL | 2,049,113 | $64,609,000 | 2.52% |
Fernwood Investment Management, LLC | 185,063 | $5,835,000 | 2.00% |
EcoR1 Capital, LLC | 1,385,276 | $43,678,000 | 1.52% |
Boxer Capital, LLC | 1,294,132 | $40,804,000 | 1.42% |
Integral Health Asset Management, LLC | 140,000 | $4,414,000 | 1.27% |
Alphabet Inc. | 1,641,497 | $51,756,000 | 1.23% |
Bellevue Group AG | 3,755,962 | $118,426,000 | 1.20% |